The liquid biopsy is an advanced cancer diagnostic test that uses bio-fluids such as blood, plasma, and urine for detecting cancer cells that are circulating in the blood.
Global Liquid Biopsy Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Liquid Biopsy market, which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F. The liquid biopsy is used to determine the most ideal cancer therapy for the patient and helps the doctor to track how a patient is responding to treatment and to check whether cancer has returned or not. The robust enhancements in NSG technology, surge in the clinical trials for the development of these tests, coupled with burgeoning cancer cases and a paradigm shift toward noninvasive procedures are some of the key drivers proliferating the growth of the global liquid biopsy market.
Automotive Segment Acquired the Considerable Market Share
Based on Circulating Biomarkers, Circulating Tumor Cells (CTCs) segment is expected to grow at a high rate in the Global Liquid Biopsy Market in 2020. The CTC's liquid biopsy tests are used to look for whole tumor cells found in the bloodstream. The rising in CTCs in a patient’s bloodstream leads to cancer progression, while a decrease leads to cancer remission. Thus, this is anticipated to drive the growth of the Liquid Biopsy market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Liquid Biopsy Market Analysis, 2020”.
Impact of COVID-19
Steady growth in the liquid biopsy market has been witnessed in the COVID-19 pandemic and it is used to improve cancer screening and care during COVID-19. Moreover, the rising partnerships among the companies to develop commercialize saliva-based liquid biopsy tests for head and neck cancers, COVID-19 testing and other viral diseases are projected to upsurge the growth of the market in the near future.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Liquid Biopsy market include Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V., etc.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation, and Statistics
Frequently Asked Questions:
Q. What is the historical year, base year and forecast year considered in the research report on Global Liquid Biopsy Market?
A. The historical data has been provided since 2016, while the base year is 2020 and the data is forecast up-to 2026.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Liquid Biopsy Market during 2021-26F?
A. The Global Liquid Biopsy Market is forecast to grow at a CAGR of 26% during 2021-26F.
Q. Who are the key competitors or players operating in Global Liquid Biopsy Market?
A. Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. are few of the leading players in the Global Liquid Biopsy Market.
Q. Which sample type segment would emerge as an opportunity area for players in Global Liquid Biopsy Market?
A. Blood is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Liquid Biopsy Market?
A. Asia-Pacific continue to grow at a highest CAGR, presenting immense opportunities for market players of Global Liquid Biopsy Market.